ORAMED PHARMACEUTICALS INC. Operating Expenses
ORAMED PHARMACEUTICALS INC. (ORMP) reported Operating Expenses of $201.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-11-10
- ORAMED PHARMACEUTICALS INC. operating expenses for the quarter ending 2022-09-30 was $11.00K, a 8.33% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. operating expenses for the quarter ending 2022-06-30 was $47.00K, a 36.49% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. operating expenses for the quarter ending 2022-03-31 was $143.00K, a 27.68% increase year-over-year.
- ORAMED PHARMACEUTICALS INC. operating expenses for the quarter ending 2021-11-30 was $67.00K, a 9.46% decline year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 9 month |
|---|---|---|---|---|
| 2022-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $58.00K derived: sum of 2 quarters · filed 2022-11-10 | $201.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $190.00K 10-Q · filed 2022-08-10 | ||
| 2022-03-31 | $143.00K 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $109.00K 10-QT · filed 2022-03-30 | |||
| 2021-11-30 | $67.00K 10-Q · filed 2022-01-11 | |||
| 2021-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $86.00K derived: sum of 2 quarters · filed 2022-11-10 | $198.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $186.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $92.00K 10-QT · filed 2022-03-30 | |||
| 2020-11-30 | $74.00K 10-Q · filed 2022-01-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |